首页> 美国卫生研究院文献>Aging (Albany NY) >Clinical challenges in cancer patients with COVID-19: Aging immunosuppression and comorbidities
【2h】

Clinical challenges in cancer patients with COVID-19: Aging immunosuppression and comorbidities

机译:Covid-19癌症患者的临床挑战:衰老免疫抑制和合并症

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

COVID-19 caused by severe acute respiratory syndrome coronavirus 2 has developed into a global pandemic. COVID-19 poses a huge threat to health care, and the shortage of medical resources caused by COVID-19 brought serious secondary disasters to elderly cancer patients who are particularly dependent on medical resources. The clinical challenges of cancer management, including aging, immunosuppression, and comorbidities, make cancer patients more vulnerable to COVID-19 with different clinical manifestations, disease severity, and outcomes. The review comprehensively analyzed the characteristics of the cancer patients under the pandemic and concluded that cancer patients were more susceptible to COVID-19, and also concluded that they were more likely to develop poor outcomes and the severe form of the disease. Three basic management strategies have been proposed to protect susceptible elderly cancer patients, find reliable indicators to monitor the course of disease, and implement effective prevention measures.
机译:Covid-19由严重急性呼吸道综合征冠状病毒2引起的,已经发展成为全球大流行。 Covid-19对医疗保健构成了巨大的威胁,Covid-19造成的医疗资源短缺给老年癌症患者带来了严重的中等灾害,特别依赖医疗资源。癌症管理的临床挑战,包括衰老,免疫抑制和可致命性,使癌症患者更容易受到Covid-19具有不同的临床表现,疾病严重程度和结果。该综述综合分析了大流行下癌症患者的特征,并得出结论,癌症患者更容易受到Covid-19的影响,并且还得出结论,它们更有可能产生差的结果和严重形式的疾病。提出了三种基本管理策略来保护易感性老年癌症患者,找到可靠的指标来监测疾病的过程,并实施有效的预防措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号